Latest Updates

ChemDesign to Receive 2019 SOCMA Educational Outreach Award

The Society of Chemical Manufacturers & Affiliates (SOCMA) is pleased to announce that ChemDesign is being recognized for its exceptional efforts to educate a new generation about the importance of specialty chemistry as part of the association’s Performance Improvement Awards program.

November 18, 2019

SOCMA Announces 2019 Performance Improvement Award Winners 

ARLINGTON, VA – SOCMA is pleased to announce that more than 20 SOCMA member facilities will receive 2019 Performance Improvement Awards. Now in its 13th year, SOCMA continues to honor companies that are leading in the areas of environmental, health, safety and security (EHS&S).

November 18, 2019

Sustained Engagement is Key for USMCA Passage

The state of play has reached a critical juncture in U.S.-Mexico-Canada Agreement (USMCA) negotiations (USMCA being the trade agreement that is set to replace NAFTA) as House Democrats continue to work through the thorniest outstanding issues, such as the pact’s labor standards and enforcement mechanism, with the Office of the U.S. Trade Representative.

November 13, 2019

China Tariffs and Impacts to the Chemical-Pharmaceutical Industry

Rigid purity and performance demands, costly infrastructure and expertise and economic and global trends often result in a lack of suppliers outside China. And, in the event that alternate sources exist, supplier(s) often lack adequate volume to make up for shortfalls from China and so SOCMA members are placed on insufficient allocation and face price increases that results in the loss of market share to foreign competitors not subject to such taxes on inputs needed to formulate products.

October 17, 2019

Lonza’s Ibex™ Solutions to Support Genmab’s Growing Clinical Portfolio

Lonza today announced an extension to its partnership with Genmab to cover preclinical and clinical development and manufacturing for a significant portion of Genmab’s pipeline. Lonza’s Ibex Solutions in Visp (CH) is designed to provide Genmab with the flexibility and speed they need to take their candidates towards IND and commercialization.

October 14, 2019